ATE86964T1 - Malonsaeurederivate und ihre synthesemethoden. - Google Patents

Malonsaeurederivate und ihre synthesemethoden.

Info

Publication number
ATE86964T1
ATE86964T1 AT87109317T AT87109317T ATE86964T1 AT E86964 T1 ATE86964 T1 AT E86964T1 AT 87109317 T AT87109317 T AT 87109317T AT 87109317 T AT87109317 T AT 87109317T AT E86964 T1 ATE86964 T1 AT E86964T1
Authority
AT
Austria
Prior art keywords
acid derivatives
malonic acid
ornithine
cysteine
tyrosine
Prior art date
Application number
AT87109317T
Other languages
English (en)
Inventor
Trapani Romano Di
Antonio Silvio Verdini
Original Assignee
Eniricerche Spa
Sclavo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eniricerche Spa, Sclavo Spa filed Critical Eniricerche Spa
Application granted granted Critical
Publication of ATE86964T1 publication Critical patent/ATE86964T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0212—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -N-C-N-C(=0)-, e.g. retro-inverso peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
AT87109317T 1986-07-16 1987-06-29 Malonsaeurederivate und ihre synthesemethoden. ATE86964T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT21143/86A IT1196500B (it) 1986-07-16 1986-07-16 Derivati dell'acido malonico e metodi per la loro sintesi
EP87109317A EP0254080B1 (de) 1986-07-16 1987-06-29 Malonsäurederivate und ihre Synthesemethoden

Publications (1)

Publication Number Publication Date
ATE86964T1 true ATE86964T1 (de) 1993-04-15

Family

ID=11177375

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87109317T ATE86964T1 (de) 1986-07-16 1987-06-29 Malonsaeurederivate und ihre synthesemethoden.

Country Status (8)

Country Link
US (1) US4914226A (de)
EP (1) EP0254080B1 (de)
JP (1) JPS6323834A (de)
AT (1) ATE86964T1 (de)
CA (1) CA1304539C (de)
DE (1) DE3784799T2 (de)
ES (1) ES2044874T3 (de)
IT (1) IT1196500B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02245277A (ja) * 1989-03-20 1990-10-01 Ntn Corp 圧電素子を用いた加振装置
US5569745A (en) * 1994-02-25 1996-10-29 Resolution Pharmaceuticals Inc. Peptide-Chelator conjugates
US6939873B2 (en) * 2000-07-26 2005-09-06 Taro Pharmaceuticals Industries Limited Non-sedating barbituric acid derivatives
US7683071B2 (en) * 2000-07-26 2010-03-23 Taro Pharmaceuticals Industries Ltd. Composition and method for improved bioavailability and enhanced brain delivery of 5,5-diphenyl barbituric acid
US6756379B2 (en) 2001-07-26 2004-06-29 Taro Pharmaceutical Industries Ltd. Non-sedating barbiturate compounds as neuroprotective agents
JP4739760B2 (ja) 2002-12-11 2011-08-03 タロー・ファーマシューティカル・インダストリーズ・リミテッド バルビツール酸誘導体を使用する運動障害の治療方法
WO2006003651A2 (en) * 2004-07-02 2006-01-12 Taro Pharmaceutical Industries, Ltd A process for preparing 1-methoxymethyl-5,5-diphenylbarbituric acid
EP2081576A4 (de) * 2006-11-14 2010-06-30 Taro Pharmaceuticals North Ame Verfahren zur verbesserung der bioverfügbarkeit für nichtsedierende barbiturate
US9249265B1 (en) 2014-09-08 2016-02-02 Sirrus, Inc. Emulsion polymers including one or more 1,1-disubstituted alkene compounds, emulsion methods, and polymer compositions
MX2013004513A (es) 2010-10-20 2013-09-26 Bioformix Inc Síntesis de metilenmalonatos sustancialmente libres de impurezas.
US9279022B1 (en) 2014-09-08 2016-03-08 Sirrus, Inc. Solution polymers including one or more 1,1-disubstituted alkene compounds, solution polymerization methods, and polymer compositions
US9828324B2 (en) 2010-10-20 2017-11-28 Sirrus, Inc. Methylene beta-diketone monomers, methods for making methylene beta-diketone monomers, polymerizable compositions and products formed therefrom
US10414839B2 (en) 2010-10-20 2019-09-17 Sirrus, Inc. Polymers including a methylene beta-ketoester and products formed therefrom
JP2014534969A (ja) 2011-10-19 2014-12-25 シラス・インコーポレイテッド メチレンβ−ケトエステルモノマー、メチレンβ−ケトエステルモノマーを製造するための方法、これらから作られる重合可能な組成物および製品
JP6553505B2 (ja) 2012-03-30 2019-07-31 シラス・インコーポレイテッド 複合材およびラミネート物品ならびにこれらを作製するための重合系
JP6188252B2 (ja) 2012-03-30 2017-08-30 シラス・インコーポレイテッド 重合性組成物の活性化方法、重合系およびこれにより形成される製品
US9234107B2 (en) 2012-03-30 2016-01-12 Sirrus, Inc. Ink coating formulations and polymerizable systems for producing the same
WO2013181600A2 (en) 2012-06-01 2013-12-05 Bioformix Inc. Optical material and articles formed therefrom
WO2014078689A1 (en) 2012-11-16 2014-05-22 Bioformix Inc. Plastics bonding systems and methods
US10607910B2 (en) 2012-11-30 2020-03-31 Sirrus, Inc. Composite compositions for electronics applications
CN105008321A (zh) 2013-01-11 2015-10-28 瑟拉斯公司 经过双(羟甲基)丙二酸酯的途径获得亚甲基丙二酸酯的方法
US9315597B2 (en) 2014-09-08 2016-04-19 Sirrus, Inc. Compositions containing 1,1-disubstituted alkene compounds for preparing polymers having enhanced glass transition temperatures
US9416091B1 (en) 2015-02-04 2016-08-16 Sirrus, Inc. Catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US10501400B2 (en) 2015-02-04 2019-12-10 Sirrus, Inc. Heterogeneous catalytic transesterification of ester compounds with groups reactive under transesterification conditions
US9334430B1 (en) 2015-05-29 2016-05-10 Sirrus, Inc. Encapsulated polymerization initiators, polymerization systems and methods using the same
US9217098B1 (en) 2015-06-01 2015-12-22 Sirrus, Inc. Electroinitiated polymerization of compositions having a 1,1-disubstituted alkene compound
US9518001B1 (en) 2016-05-13 2016-12-13 Sirrus, Inc. High purity 1,1-dicarbonyl substituted-1-alkenes and methods for their preparation
US10196481B2 (en) 2016-06-03 2019-02-05 Sirrus, Inc. Polymer and other compounds functionalized with terminal 1,1-disubstituted alkene monomer(s) and methods thereof
US10428177B2 (en) 2016-06-03 2019-10-01 Sirrus, Inc. Water absorbing or water soluble polymers, intermediate compounds, and methods thereof
US9567475B1 (en) 2016-06-03 2017-02-14 Sirrus, Inc. Coatings containing polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
US9617377B1 (en) 2016-06-03 2017-04-11 Sirrus, Inc. Polyester macromers containing 1,1-dicarbonyl-substituted 1 alkenes
KR20220069949A (ko) * 2019-09-26 2022-05-27 아지노모토 가부시키가이샤 유기 물질의 유도체의 제조방법 및 유기 물질을 포함하는 시료의 분석 방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3013069A (en) * 1958-07-15 1961-12-12 American Cyanamid Co 2-(substituted-benzyl)-1, 3-propane-dicarboxylic acids
AR194578A1 (es) * 1970-11-09 1973-07-31 Kendall & Co Un procedimiento para preparar acidos 5-sustituidos-5-fenilalquil barbituricos y un compuesto intermedio obtenido durante dicho procedimiento
FR2211007A5 (de) * 1972-12-15 1974-07-12 Ugine Kuhlmann
IT1212508B (it) * 1981-12-22 1989-11-22 Anic Spa Analoghi retro - invertiti dei penta - ed esapeptidi c - terminali della sostanza p. utili come vasodilatatori
IT1190891B (it) * 1982-06-24 1988-02-24 Anic Spa Metodo per la sintesi in fase solida di polipeptidi retroinvertiti
US4499079A (en) * 1982-11-18 1985-02-12 E. R. Squibb & Sons, Inc. Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides
EP0253190B1 (de) * 1986-07-16 1992-12-30 ENIRICERCHE S.p.A. Teilweise retro-invertierte Analoge des Tuftsin, Methode zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten

Also Published As

Publication number Publication date
EP0254080B1 (de) 1993-03-17
ES2044874T3 (es) 1994-01-16
IT8621143A0 (it) 1986-07-16
JPS6323834A (ja) 1988-02-01
EP0254080A3 (en) 1989-05-31
DE3784799T2 (de) 1993-06-24
CA1304539C (en) 1992-06-30
US4914226A (en) 1990-04-03
DE3784799D1 (de) 1993-04-22
IT1196500B (it) 1988-11-16
EP0254080A2 (de) 1988-01-27

Similar Documents

Publication Publication Date Title
DE3784799D1 (de) Malonsaeurederivate und ihre synthesemethoden.
NO911787D0 (no) Peptidaminer samt fremgangsmaate for fremstilling derav.
ATE176483T1 (de) Derivate des parathormons
MX9805289A (es) Nuevos derivados de n-(arilsulfonil)aminoacidos que tienen una afinidad por los receptores de la bradicinina.
ES2168354T3 (es) Protegrinas.
DK1086124T3 (da) Nye cyclosporiner
ATE54410T1 (de) Oligopeptid-derivate, deren herstellung und deren verwendung als hautfreundliche tenside.
ATE3283T1 (de) Somatostatin-analoge peptide, ihre herstellung und verwendung, sie enthaltende pharmazeutische praeparate und deren herstellung.
KR900009692A (ko) 레트로바이러스 프로테아제 억제제
KR950032165A (ko) 토코페롤 유도체
ATE112289T1 (de) Hämoregulierende peptide.
ATE242202T1 (de) Peptide
DE68925806T2 (de) C63-Amidderivate von 34-de(acetylglucosaminyl)-34-deoxy-teicoplaninen
KR890013061A (ko) 폴리펩티드 유도체
ATE92315T1 (de) Aminosaeurederivate enthaltende antikonvulsive zusammensetzungen und verwendung dieser aminosaeurederivate.
ES8605769A1 (es) Un procedimiento para la preparacion de un peptido
EP0264802A3 (en) Synthesis of peptide-aminoalkyl amides and peptide hydrazides by the solid phase method
FI911784A (fi) Ny behandlingsmetod med benzodiazepinfoereningar.
ATE46347T1 (de) Immunostimulierende peptide.
DE69127718D1 (de) Galactosamin-substituierte poly-omega-substituierte L-Glutaminsäure und/oder -Asparaginsäure
TH13640A (th) Hemoregulatory peptides เปปไทด์ที่ควบคุม
ATE137741T1 (de) Aminosäurederivate zur peptidsynthese

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee